Ticker Details
Lexicon Pharmaceuticals, Inc. Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.02B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 3.99%
Avg Daily Range (30 D):	$0.07 | 2.94%
Avg Daily Range (90 D):	$0.07 | 3.21%

Institutional Daily Volume
Avg Daily Volume:	1.48M
Avg Daily Volume (30 D):	2.56M
Avg Daily Volume (90 D):	2.63M

Trade Size
Avg Trade Size (Sh.):	281
Avg Trade Size (Sh.) (30 D):	212
Avg Trade Size (Sh.) (90 D):	229

Institutional Trades
Total Institutional Trades:	1,042
Avg Institutional Trade:	$1.53M
Avg Institutional Trade (30 D):	$.76M
Avg Institutional Trade (90 D):	$2.78M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.39M
Avg Closing Trade (30 D):	$.76M
Avg Closing Trade (90 D):	$3.29M
Avg Closing Volume:	255.95K

News

Jun 3, 2026 @ 12:00 PM Lexicon to Present Data at the American Diabetes A... Source: Lexicon Pharmaceuticals, Inc.

May 14, 2026 @ 5:50 PM Navigating Life with Hypertrophic Cardiomyopathy Source: Michael French

Apr 17, 2026 @ 12:00 PM Lexicon to Present Data at the American Academy of... Source: Na

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Na

Feb 6, 2026 @ 10:17 PM Lexicon Announces Closing of Approximately $94.6 M... Source: Globe Newswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.15	$-.07	$
Diluted EPS	$-.15	$-.07	$
Revenue	$41.47M	$.69M	$21.1M
Gross Profit	$41.11M	$.65M	$20.99M
Net Income / Loss	$-61.12M	$-31.78M	$-1.04M
Operating Income / Loss	$-54.5M	$-26.54M	$-1M
Cost of Revenue	$.36M	$.04M	$.11M
Net Cash Flow	$-9.44M	$-26.17M	$3.76M
PE Ratio

Splits
May 21, 2015	1:7